Last reviewed · How we verify

Standard multimodal analgesia

Centre Hospitalier Universitaire de Nīmes · FDA-approved active Small molecule

Standard multimodal analgesia combines multiple pain-relief medications acting on different mechanisms to provide synergistic pain control.

Standard multimodal analgesia combines multiple pain-relief medications acting on different mechanisms to provide synergistic pain control. Used for Acute postoperative pain, Chronic pain conditions, Cancer pain.

At a glance

Generic nameStandard multimodal analgesia
SponsorCentre Hospitalier Universitaire de Nīmes
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

This is a therapeutic approach rather than a single drug, typically combining opioids, non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and/or adjuvant analgesics (such as gabapentinoids or local anesthetics) to target pain through different pathways simultaneously. By using agents with complementary mechanisms—such as peripheral anti-inflammation, central pain modulation, and neuropathic pain relief—multimodal analgesia achieves superior pain control while potentially reducing the required dose of each individual agent and associated adverse effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results